Unbiased Analysis of Today's Healthcare Issues
This is the title of a paper published today with co-authors Suepattra May, Caroline Huber, Meaghan Roach, Wade Aubry, Darius Lakdawalla, John Kane, and Felicia Forma. The subtitle is “Qualitative Case Study of Glucose Monitoring Technology“. The abstract is below. Background: Evaluation of patients with serious mental illness (SMI) relies largely on patient or caregiver…
That is the title of my article in MedCityNews. I discuss the evolution of value measurement, digital medicine, and the importance of reducing inequality. Below is an excerpt: While efficacy, safety and cost still form the core of a treatment’s value, how a treatment is administered is now becoming of primary importance in a world…
In the past I have written about the limited evidence that wellness program work. So we should see that employers are abandoning these programs or at least scaling back? According to one recent study, however employers are actually increasing investments in wellness programs. The study surveys employers from over 500 companies with more than 100…
FDA faces an near existential crisis: digital. New digital technologies have the capability to improve the way care is delivered to patients. The question is, how do we make sure it is safe? The FDA is certainly good at making sure drugs and devices are safe; in the case of digital however, it is less…
With co-authors Katalin Bognar, Michelle Brauer, Lauren Zhao, Rick Hockett, Michael O’Neil and Anupam Jena, I am excited to announce that our study “The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States” was published in the Journal of Medical Economics today. The full abstract is below. …